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Summary 
The expression of class I  major histocompatibility complex antigens on the surface of ceils 
transformed by adenovirus 12 (Ad12) is generally very low, and correlates with the high oncogenicity 
of this virus. In primary embryonal fibroblasts from transgenic mice that express both endogenous 
H-2 genes and a miniature swine class I gene (PD1),  Ad12-mediated transformation results in 
suppression of cell surface expression of all class I antigens. Although class I mRNA levels of 
PD1  and H-2D  b are  similar  to  those in nonvirally transformed cells, recognition of newly 
synthesized class I molecules by a panel of monoclonal antibodies is impaired, presumably as 
a result of inefficient assembly and transport of the class I molecules. Class I expression can be 
partially induced by culturing cells at 26~  or by coculture of cells with dass I binding peptides 
at 37~  Analysis of steady state mRNA levels of the TAP1 and TAP2 transporter genes for 
Ad12-transformed cell lines revealed that they both are significantly reduced, TAP2 by about 
100-fold and TAP1 by 5-10-fold.  Reconstitution of PD1 and H-2D b, but not H-2K  b, expression 
is achieved in an Ad12-transformed cell line by stable transfection with a TAP2, but not a TAP1, 
expression construct. From these data it may be conduded that suppressed expression of peptide 
transporter genes, especially TAP2, in Ad12-transformed cells inhibits cell surface expression of 
class I molecules. The failure to fully reconstitute H-2D  b and H-2K  b expression indicates  that 
additional factors are involved in controlling class I gene expression in Ad12-transformed cells. 
Nevertheless,  these results suggest that suppression of peptide transporter genes might be an 
important mechanism whereby virus-transformed cells escape immune recognition in vivo. 
M 
HC class I genes play key roles in numerous immuno- 
logical processes. Among these are the presentation 
of "foreign" antigens for recognition by CTLs (1). By this 
mechanism, the immune system is able to control infectious 
diseases and the growth of tumor cells (2, 3). Indeed, tumors 
of various origin have been shown to express low levels of 
class I antigens, a characteristic that might contribute to their 
escape from immune surveillance (4). In support of this, Tanaka 
et al.  (5) reported that the reexpression  of class I antigens 
inhibited tumor growth. However,  transfection of cell lines 
by class I genes does not always result in the expression of 
class I molecules on the cell surface. Weis and Seidman (6) 
reported that transfection of L cells by a class I gene resulted 
in increased levels ofdass I mRNA, but failed to significantly 
increase the cell surface expression of class I antigens. Thus, 
the suppressed expression  of class I molecules by cells may 
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occur during transcription of the genes, or during synthesis, 
assembly, and transport to the cell surface. 
Transport of class I molecules to the cell surface depends 
on their assembly with peptides, which are usually 8-9 amino 
acids long (7). Several researchers (8-10) have demonstrated 
that such peptides arise from cleavage of proteins in the cytosol 
and are actively transported into the endoplasmic reticulum 
(ER) 1, where assembly with class I molecules takes place. 
Presumably,  if the antigen processing machinery of the cell 
is functioning normally, the tumor-associated antigens and 
antigens originating from oncogenic viruses generate such 
peptides (11-13). After assembly, the molecules are transported 
through the Golgi apparatus to the cell surface. Klar and HL,  n- 
merling (14) showed that tumor cells, such as the lung carci- 
noma CMT 64.5 and the fibrosarcoma BC2, can synthesize 
1Abbreviations used in  this paper: Adl2,  adenovirus  12;  •2m,  /~2- 
microglobulin; ER, endoplasmic reticulung F.U., fluorescence units; MEF, 
mouse embryonal fibroblasts. 
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these are only assembled after treatment with 3,-interferon. 
Furthermore,  mutant  cells with  deletions or mutations  in 
the MHC locus, but with intact class I genes,  such as the 
murine  RMA-S and the human T2 or 721.174  cells,  have 
drastically reduced cell surface levels of class I, as a result of 
a defect in peptide transport  into the EK (10,  15,  16).  Ex- 
pression can be restored by transfecting  the cells with the 
MHC-encoded peptide transporters TAP1 and TAP2 (17, 18). 
tLecently,  Kestifo et al.  (19) demonstrated  that  tumor cell 
lines differ in their ability to process antigens, a phenomenon 
that is correlated with poor class I expression and low mRNA 
levels of both peptide transporters  and proteasome compo- 
nents.  However, this study did not address the question of 
whether poor antigen processing is associated with transfor- 
mation, or represents the natural regulation of class I expres- 
sion in the  tissue of origin. 
Tumors transformed by the highly oncogenic adenovirus 
12 (Ad12)  have been used as model systems to demonstrate 
a direct correlation between tumorigenicity and lack of host 
immune responses due to decreased class I expression (20-22). 
Whereas both Ad5 and Ad12 transform primary fibroblasts 
in vitro,  tumors are generated in vivo only by Ad12-trans- 
formed cells that are deficient in class I expression. Down- 
regulation of class I expression was reported to occur at both 
the transcriptional (23-26) and posttranscriptional levels (27). 
In our previous reports we described a large panel of cell lines 
transformed  by Ad12,  and  compared  them  to  both  AdS- 
transformed cell lines and immortalized ("normal") cell lines 
derived from the same pool of fibroblasts (27). The parental 
fibroblasts were prepared from transgenic mice which express 
both endogenous class I genes and a miniature  swine dass 
I transgene (PD1) that is not located in the MHC locus. Al- 
though all cell lines express dass I mRNA, the levels of class 
I antigens, but not other receptors (such as MAC-2 and CD44), 
are significantly decreased in most Ad12-transformed cell lines. 
Comparison  of the three class  I gene transcripts  in Ad12- 
transformed cells revealed that the levels of PD1 and H-2D 
are about normal, whereas the H-2K level is two- to fivefold 
lower (Winogard,  S., tL.  Kotem-Yehudar,  and R. Ehrlich, 
manuscript  in preparation).  Immunoprecipitation  analyses 
with or without endo-B-N acetylglucosaminidase H  (endo 
H) treatment,  revealed that Ad12-transformed cell lines are 
deficient in both class I molecule synthesis and the ability 
to transport these molecules through the Golgi apparatus  (28). 
Both H-2 and PD1 transport were inhibited,  implying the 
existence of a general mechanism that affects maturation of 
all class I products in these cells. These results raised the pos- 
sibility that transformation by certain viral serotypes can affect 
peptide transport. In this paper, we pursue the causes of aber- 
rant transport  and expression of class I molecules in Ad12- 
transformed  cells. 
Materials and Methods 
Mice.  C57B1/10 mice, which are transgenic  for a miniature 
swine class I antigen, PD1 (PD1 transgenic mice), have been previ- 
ously described (27, 29). The mice, which are homozygnus for the 
transgene, were bred at the Tel Aviv University breeding facility. 
Cell Cultures.  All the cell lines were derived from cultured mouse 
embryonal fibroblasts (MEF) as previously described (27). M1 was 
derived from spontaneous in vitro immortalization  of MEF after 
growth crisis (27). VAD12.78, VAD12.79, and VAD12.42 were 
transformed by infection of MEF with Ad12 (27). A501, A503, 
and A505 were transformed by transfection of MEF with Ad5- 
Xhol-C fragment in a PSV2Neo plasmid (30, 31), followed by se- 
lection with 800 gg/ml of 0418 (Sigma Chemical Co., St, Louis, 
MO). The plasmids were a gift from Dr. A. Van der Eb (Univer- 
sity of Leiden, Leiden, The Netherlands).  ME1 and ME5 were de- 
rived from transformation of BALB/c-MEF by Ad5 and were a gift 
from Dr. A. M. Lewis (National Institute of Allergy and Infec- 
tious Disease, National Institutes of Health,  Bethesda, ME)) (32). 
The cell lines were maintained in DMEM, supplemented with 
2 mM glutamine, 10% FCS, penicillin, streptomycin, gentamycin, 
and amphotericin B at the recommended concentrations (33). Media 
and supplements were purchased from Biological Industries,  Bet 
Haemek,  Israel. 
Stable Transfection.  Ad12-transformed cells (VAD12.79) were 
transfected by the calcium phosphate-DNA copredpitation method 
(28). The transfection cocktail contained 10 gg plasmid DNA and 
5 ~g of carrier DNA (sheared salmon sperm DNA; Sigma Chem- 
ical Co.). 24 h after transfection, the cells were washed with PBS, 
and after a further 24 h the medium was supplemented with 800 
mg/ml G418 (Sigma Chemical Co.). The transfected ceils were ei- 
ther grown to confluence and analyzed as a bulk mixture of cells, 
or individual clones were isolated and expanded in culture. 
Probes and Plasraids.  The PDl-specific probe is a SacI-BamHI 
fragment containing exon 2-7 of the PD1 gene (29); the H-2 probe 
is an  EcoRI-HindIII fragment  derived from pH-2a33  (H-2K  d) 
(34); the 132m probe is a PstI-PstI fragment  from ~2m eDNA 
cloned in pBR322 (35); the actin probe is a PstI-PstI fragment 
from chicken f3 actin eDNA cloned in pBR322 (36); the AdSEla 
probe is an EcolLI-EcoKI  fragment  containing  the Ela of AdS 
cloned in RSVNen and was a gift from Dr. A. Van der Eb (Univer- 
sity of Leiden); and the TAP1 and TAP2 probes are XbaI-HindIII 
and KpnI-KpnI fragments containing  TAP1 and TAP'2 cDNAs, 
respectively cloned in pcDNAI Neo (Invitrogen, San Diego, CA), 
were a gift from Dr. J. J. Monaco (University of Cincinnati,  Cin- 
cinnati,  OH) (37). 
Antibodies.  The antibodies used for FACS  |  analyses and their 
specificities are: 20.8.4S, which recognizes  H-2K  b and  H-2Kd; 
28,14.8, which recognizes an epitope on ce3 domain of H-2D  b and 
H-2L  d heavy chains with  or without  associated B2m (38-40); 
27.11.13, which recognizes H-2D  s and H-2IY; B8.24.3,  which 
recognizes H-2Kb; and FT85A, which recognizes a public deter- 
minant on swine lymphocyte antigens (SLA) (41). FITC-conjugated 
goat anti-mouse IgG was purchased from Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA). 
Induction of Class IExpression.  The cells were incubated for 18 h 
with the peptides listed in Table I in serum-free media (Bio MPM 
1, multipurpose  serum-free medium for adherent cells; Biological 
Industries).  Peptides were synthesized, purified,  and analyzed as 
previously described (42). 
FACS  ~ Analysis.  The ceUs were harvested by mild trypsiniza- 
tion, followed by washing with media supplemented with 5% FCS 
and 0.01% sodium azide. Approximately  106 cells were incubated 
at 4~  with the appropriate concentration  of the first antibody 
for 30 rain,  washed, and then incubated in the dark for another 
30 min with the second antibody. Controls were stained with a 
first nonrelevant antibody and a second antibody. The cells were 
washed with PBS and the fluorescence intensity analyzed by a cell 
sorter (Becton Dickinson  & Co.,  Mountain  View, CA). 
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Peptide  Position*  Restriction  Sequence  Reference 
Flu NP  366-374  D b  ASNFNMF:TM  43-45 
AdS Ela  234-243  D b  SGPSNTPPE I  11,  45 
VSV NP  52-59  K  b  RGYVYQGL  7,  45 
OVA  257-264  K b (Db)  t  S I I NFEKL  45,  46 
Sendai  NP  324-332  K b (Db)  f  FAPGNYPAL  45,  47 
Flu PR8 NP  147-155  K d  TYQRTRALV  44,  45 
Flu JAP HA  529-537  K d  I YATVAGSL  45,  48,  49 
Flu PR8 HA  533-541  K a  I YSTVASSL  45,  50 
p18-HIV  318-327  D a  RGPGRAFVT  I  51 
Tum-p35B  133-141  D a  NGPPHSNNF  52 
CMV  168-176  L  a  YPHFMPTN L  53 
* Residue number of the peptide in the native protein. 
t Sendai NP 324-332 is restricted to H-2K  b but it also was shown to stabilize H-2D  b cell surface expression (54, 55). OVA 257-264 was shown 
to promote the expression of H-2K  b and to some extent H-2D  b (55). 
RNA Analysis.  Cytoplasmic RNA was prepared by the method 
of White and Bancroft (56) as previously described  (27). Enrich- 
ment for poly A mRNA was done according to Sambrook et al. 
(57).  10 #g of poly A-enriched mRNA was denatured and run 
on  a  1.2%  formaldehyde/formamide  agarose  gel,  blotted  into 
Hybond-N membrane (Amersham International, Little Chalfort, 
UK) and hybridized with the appropriate probe,  which was la- 
beled with (x-[~2p]dCTP (Rotem Industries, Diom, Israel) using 
a Random Priming labeling kit (United States Biochemical Corp., 
Cleveland,  OH). 
The hybridization solution contained 4  x  SSC, 50%  forma- 
mide, 0.2% SDS, 0.1% polyvinylpyrrolidone, and 100 #g/ml shea~ 
salmon sperm DNA. Hybridizations were carried out at 42~  fol- 
lowed by washes with 2  x  SSC, 0.1% SDS at room temperature, 
and 0.2  x  SSC in temperatures  ranging between 55 and 65~ 
The blot was exposed to RX x-ray films (Fuji, Tokyo, Japan)  and 
the resulting bands were scanned  by a densitometer. 
The blot, after stripping with a boiling solution of 0.1% SDS, 
was used seven times for hybridizations. 
Results 
Cell Surface Expression of Class I Antigens Is Decreased  After 
Transformation with Adl2.  The following studies were car- 
ried out with a representative  normal cell line obtained by 
spontaneous immortalization of MEF from C57B1/10.PD1 
mice (M1), Ad12- and Ad5El-transformed MEF from the same 
mice (27, 28), and Ad5-transformed MEF from BALB/c mice 
(32). The cell surface  level of expression and the percent positive 
cells for H-2 antigens and the transgene product PD1 were 
compared in the adenovirus-transformed and the normal cell 
lines (Fig.  1 and Table 2). The Ad12-transformed cell lines 
VAD12.42 and VAD12.79 expressed very low levels of all class 
I antigens, as reflected both by the percent of positive cells 
in the population (Table 2) and the relative fluorescence per 
cell (Fig. 1 and Table 2). Cell lines derived by transformation 
of MEF with Ad5E1 (A501 and A505) expressed higher 
levels of class I antigens than M1. For comparison, we ana- 
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Figure  1.  Cell  surface  expression of 
class I antigens is decreased after trans- 
formation with Ad12. Cell surface ex- 
pression of class I  antigens on  the 
normal cell line (M1), Ad12-transformed 
cell  lines (VAD12.42, VAD12.79), 
Ad5El-transformed cell lines (A505, 
A501), and Ad5-transformed  cell lines 
(ME1,  ME5) was  analyzed by  im- 
munofluorescence  staining with the fol- 
lowing antibodies: PT85A (anti+PD1) 
(~),  20.8.4S  (anti-H-2K  b,  anti-H- 
2K  d)  (---..~),  28.14.8 (anti-H-2D  b, 
anti-H-2L  a) (--~) and 27.11.13 (anti-H- 
2D  b, anti-H-2D  a) (.--~).  The nega- 
tive control (staining with a nonrele- 
vant first antibody) is not marked with 
an arrow. 
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Is Decreased after Transformation witk Adl2 
Percent positive cells (mean F.U./CeU)* 
Antibody 
trr85A  20.8.4S  27.11.13  28.14.8 
(anti-  (anti-  (anti-  (anti- 
Cell line*  PD1)  H-2Kb,K  d  )  H-2Db,D  d)  H-2Db,L  d  ) 
M1  84 (150)  54 (20)  69 (35)  80 (60) 
VAD12.79  22 (15)  3 (9)  20 (15)  32 (15) 
VAD12.42  0 (4)  0  (4)  0 (4)  0 (4) 
A501  95 (900)  85  (150)  91 (200)  97 (600) 
A505  85 (600)  62  (60)  93  (200)  83  (200) 
ME1  -  35  (15)  38  (15)  39  (15) 
ME5  --  83  (150)  81  (150)  78  (150) 
*  M1 is a normal cell line; VAD12.79 and VAD12.42 are Ad12-transformed 
cell lines; A501 and A505 are ElAd5-transformed  cell lines; ME1 and 
ME5 are Ad5-transformed cell lines. 
* The percent of positive cells and their mean fluorescence were deter- 
mined by comparing with the staining obtained with a nonrelevant first 
antibody. 
lyzed the AdS-tranfformed cell lines ME1 and ME5 described 
by Haddada et al. (32) who also showed that ME5 expresses 
higher levels of class I  antigens than ME1. 
Effects of Low Temperature on Expression of Class I Epitope, 
on the Su[face of Adl2-transformed  Cells.  Expression of class 
I molecules on the surface of RMA-S cells can be enhanced 
by culture at lower temperatures (58). To determine whether 
the level of dass I molecules on the surface of/kl12-transformed 
cells is increased after incubation at reduced temperatures, 
we cultured the cell lines for 18 h  at 26~  and examined 
cell surface expression by FACS  |  analyses. As shown in Fig. 
2, class I expression was not enhanced in the normal cell line 
(M1), whereas the expression of epitopes recognized by PT85A 
(anti-PD1) were enhanced in Ad12-transformed cell lines. A 
two-fold increase in the mean fluorescence/cell of PDl-positive 
cells was also observed (data not shown). Nevertheless, PD1 
expression reached <50% of the maximal level expressed in 
M1 cells. Only one cell line (VAD12.79)  demonstrated an 
increased number of H-2 positive cells after incubation at 26~ 
(Fig. 2), but even for this cell line the mean fluorescence/cell 
did not change significantly (data not shown). 
Specific Peptides Induce Expression of Class I Molecules on the 
Surface of Adl2-transformed  Cells.  The enhanced expression 
of PD1 at lower temperatures raised the possibility that pep- 
tide transport is inefficient in these cells. Class I molecules 
in cells lacking peptide transporters, and in turn, exhibiting 
low levels of the relevant peptides in the ER, may be stabi- 
lized by extracellular peptides (43, 47). To determine whether 
this was the case with our cell lines,  we cultured the cells 
in the presence of peptides known to bind H-2D  b or H-2K  b. 
To prevent enzymatic degradation, or effects mediated by 
bovine 32m,  all  the incubations were done in  serum-free 
media. The peptides used are listed in Table 1. Two H-2D b- 
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Figure 2.  Effects  of incubation  at reduced temperature on cell surface expression ofchss I antigens in Adl2-transformed cell lines. Cell surface expres- 
sion of PD1, H-2K  b, and H-2D  b in Ad12-transformed cell lines (VAD12.79, VAD12.42, VAD12.78) (A-C), and the immortalized cell line (M1) (D) 
was analyzed after incubation of cells at 37~  (ll) and 26~  ([]). The antibodies used were FT85A (anti-PD1), 20.8.4S (anti-H-2Kb), B8.24.3 (anti- 
H-2Kb), and 28.14.8 (anti-H-2Db). 
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Figure  3.  Effects of H-2Db-specific 
peptides  on cell surface expression of 
class I antigens in Ad12-transformed cell 
lines. Cell surface expression of H-2D  b 
(A and B), PD1  (C),  and H-2K  b (D) 
on  the  Ad12-transformed  cell  line 
VAD12.79 was analyzed after incuba- 
tion of cells for 18 h with serum-free 
medium (Cont.), or with the Flu NP 
(NP) or Ad5 Ela (Ela) peptides at var- 
ious concentrations (10, 25, and 50/~M, 
as indicated in the figure) and compared 
with that of M1 incubated  in serum- 
free  medium  (M1). The  antibodies 
used were 27.11.13 (anti-H-2D  b) (,4), 
28.14.8  (anti-H-2D  b)  (B),  PT85A 
(antbPD1)  (C),  and  20.8.4  (anti-H- 
2K  b) (O). 
and  three H-2Kb-restricted  peptides  were used;  however, 
the H-2Kb-restricted peptides, Sendai NP 324-332 and Ova 
257-264,  have been also shown to somewhat stabilize H-2D  b 
expression (54,  55).  Two H-2D a-,  three H-2K  d-, and one 
H-2La-specific peptides were used to analyze effects on class 
I  expression by ME1  cells,  which  are of BALB/c origin. 
Whereas Fig. 3, A  and B show that the H-2Db-specific pep- 
tides enhanced H-2D b expression on VAD12.79  by two- to 
threefold, resulting in percent positive cells equal to that in 
M1 (data not shown), PD1 and H-2K  h expression were not 
further enhanced by these peptides (Fig. 3, C and D). Similar 
results were observed with the addition of H-2Db-specific 
Table  3.  H-21Y-restricted Peptides  Induce Specific  Class  I  Expression  on Ad12-transformed  Cells 
Cell Line 
Peptide *  M 1  A50 1  VAD 12.79  VAD 12.42 
Antibody  Flu NP  Percent  Positive Cells  +  S.E.t 
PT85A  -  76.0  89.5  +  5.5  39.3  _+  9.9  15.5  +  0.5 
(anti-PD1)  +  81.0  82.5  +  6.5  38,7  _+  9.3  24.5  +  7.5 
20.8.4S  -  86.0  76.0  +_  2.0  7.0  _+  5.1  4.5  _+  4.5 
(anti-H-2K  b)  +  72.0  72.5  +  3.5  5.7  +_  3.2  3.5  +_  3.5 
27.11.13  -  87.0  71.0  +  4.0  21.0  _+  9.9  3.5  _+  3.5 
(anti-H-2D b)  +  80.0  90.5  +  1.5  47.3  _+  9.6  44.5  _+  11.5 
28.14.8  -  77.0  88.0  _+  2.0  29.6  +  9.2  9.0  _+  0.05 
(anti-H-2D b)  +  88.0  79.5  +  5.5  49.3  +  10.1  52.5  _+  2.5 
* Treatment with peptides  (20 #M) and  FACS  |  analysis were done as described in Materials  and Methods. 
S.E., Standard  Error. 
481  Rotem-Yehudar  et al. peptides to VAD12.42 cells (Table 3). None of the peptides 
induced additional  class  I  expression  on  M1  or  E1Ad5- 
transformed cell lines  (Table 3). 
A two- to threefold enhancement of class I expression could 
be obtained for H-2K  b, but required the addition of higher 
concentrations of H-2Kb-specific peptides (150 ~M) (Fig. 4). 
In contrast to the results obtained following treatment by 
H-2Db-specific  peptides where more than 50% of the cells 
expressed detectable levels of class I antigens, cells expressing 
detectable levels of H-2K  b after treatment with the relevant 
peptides consisted only 15-35% of the population. The fact 
that H-2K  b expression  could not be induced to the same 
extent as the H-2D  b expression  is consistent with the ob- 
served transcriptional downregulation of the H-2K  b gene 
(Winograd et al., manuscript in preparation). Treatment with 
OVA 257-264 resulted in some induction of H-2D  b expres- 
sion as expected, but only at the highest peptide concentra- 
tion (150/zM). H-2Kb-spedfic peptides did not affect PD1 
expression.  In contrast to the induction of cell surface ex- 
pression of class I molecules after  the treatment of Ad12- 
transformed cells with spedfic peptides, the levels of dass I 
antigens on the surface of the Ad5-transformed cell lines, ME1 
and ME5, the Ad5El-transformed and M1 cell lines, were 
not increased by incubation with the peptides listed in Table 
1 (data not shown). Thus, decreased cell surface expression 
of dass I antigens in the Ad12-, but not in the AdS-transformed 
cell lines is apparently caused by a lack of peptides in the ER. 
Preincubation of cells with exogenous B2m was previously 
shown to facilitate the association  of peptides with class I 
heavy chains (58-60).  To examine the effect of such treat- 
ment on our cell lines they were incubated with recombinant 
human B2m, or with a mixture of peptides and human B2m. 
Neither the addition of human B2m alone, nor human B2m 
plus the highest tested peptide concentration, resulted in fur- 
ther enhancement of class I expression (results not shown). 
Thus, exogenously added ~m did not facilitate class I ex- 
pression in this system. 
Suppression of Peptide Transporter Genes in Adl2-transformed 
Cells.  The apparent deficiency of peptides for assembly and 
transport of class I molecules to the cell surface, raised the 
possibility that peptide transporter genes are downregulated 
in Ad12-transformed cell lines. Hybridization of total RNA 
from seven individual Ad12-transformed call lines with TAP 
derived probes revealed that the levd of peptide transporter 
mRNA, particularly TAP2, is significantly decreased com- 
pared to that in Ad5-transformed cell lines. However, because 
the expression of both TAP1 and TAP2 was very low in MEF 
and MEF derived cell lines, poly A mRNA was isolated in 
order to quantitatively compare TAP expression in the different 
cell lines. Fig. 5 and Table 4 summarize the results of Northern 
hybridization analyses of poly A mRNA isolated from the 
various  cell lines with class I, ~m,  Ad5Ela,  and peptide 
transporter-derived probes. The most marked difference be- 
tween Ad12-transformed and the other cell lines was in the 
level of expression of the TAP2 gene. The hybridization signal 
with the TAP2 probe was very low in Ad12-transformed cells 
(at least a 100-fold decrease in TAP2 mRNA in VAD12.42 
and VAD12.79 as compared with M1).  In call lines trans- 
formed by AdSE1 (A501 and A505), there was a four- to 
fivefold increase in the steady state level of TAP2, compared 
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Figure 4.  Effects of H-2Kb-spe  - 
cific peptides on cell surface expres- 
sion of class I  antigens in Ad12- 
transformed cell lines. Cell surface 
expression of H-2K  b (A  and B), 
PD1 (C),  and H-2D  b (D) on the 
Ad12-transformecl  cen line VAD12.79 
was  analyzed after  incubation of 
cells for 18 h in serum-free medium 
(Cont) or with 150/~M of OVA, 
Sendai NP (Send), and VSV NP 
(VSV) and compared with that of 
M1 incubated  in serum-free  medium 
(MI).  The  antibodies  used  were 
20.8.4S (anti-H-2K  b) (.4), B8.24.3 
(anti-H-2Kb)  (B), 1~85A  (anti- 
PD1)  (C),  and  28.14.8 (anti-H- 
2Db) (D). 
482  Downregulation of Peptide Transporter Genes in Transformed Cells Figure  5.  Expression  of peptide transporter genes is suppressed  in cell 
lines transformed by Ad12. Electrophoresis on formaldehyde/formamide 
agarose gel was carried out with 10 #g of poly A enriched mRNA from 
the  normal cell line (M1), Ad12-transformed cell lines (VAD12.79, 
VAD12.42), Ad5El-transformed  cell  lines (A501, A503, A505), and Ad5- 
transformed cell  lines (ME1, MES). RNA was transferred to nylon mem- 
brane and hybridized  as indicated in Materials and Methods with probes 
specific  for the following  transcripts; TAP1, TAP2, H-2, PD1, B2m (/~zM), 
AdSEla (E1A), and actin. The blot was stripped between hybridizations 
as indicated in Materials and Methods. The results of the densitometric 
analysis are summarized in Table 4. 
with  M1.  ME1  and  ME5,  which  originated  from  Ad5- 
transformation  of BALB/c fibroblasts and one of the AriSE1 
transformed cell lines (A503), expressed similar levels of TAP2 
mRNA  to those in  M1. 
TAP1 gene expression was suppressed by 5-10-fold in Adl2- 
transformed,  compared with M1 cells.  By contrast,  in two 
cell lines transformed by Ad5E1 (A501 and A505) there was 
a 10-fold increase in the steady state level of TAP1 transcripts 
in comparison  to M1 cells.  A  two-  to threefold induction 
in TAP1 expression also occurred in A503  and ME1.  One 
of the major differences between ME1 and ME5 is the ab- 
sence of Ela expression in ME5 (Fig. 5), although Elb mRNA 
is expressed (results not shown). The absence of Ela proteins 
in ME5 and the low level of Ela in A503  could relate to 
the difference in TAPl-gene expression between the cell lines. 
Reconstitution of Class I Expression in an AdI2-transformed 
Cell Line Stably Transfected  with a TAP2 Expression Vector.  To 
determine whether class I expression can be reconstituted by 
expression of peptide transporter genes, an Ad12 transformed 
cell line (VAD12.79),  was transfected with either TAP1, TAP2, 
a  mixture  of TAP1  and  TAP2  expression constructs,  or a 
PSV2Neo control construct. TAP1 and TAP2 were transcribed 
from the CMV promoter in these constructs.  Since the ne- 
omycin gene and the TAP cDNAs were located on the same 
plasmid,  all transfectants were pooled and class I expression 
was analyzed by FACS  |  In addition, several individual dories 
were expanded in culture and analyzed. The FACS  |  analyses 
of the bulk transfected  cultures is shown in Fig. 6, B-D. TAP1 
transfection did not increase the expression of any of the class 
I molecules (Fig.  6 C compared with A  and B) although the 
level of TAP1 transcripts was 10-fold higher in the transfected 
cells  than in M1  (data not  shown).  TAP2 transfection par- 
tially reconstituted class I expression in the bulk culture cells 
(Fig. 6 D). PD1 expression was increased on 55% of the cells 
and mean fluorescence units  (F.U.)/cell increased from 9 to 
22 (Fig.  6/9/). The pattern of PD1 expression suggested the 
existence of three subpopulations in the pool of transfectants: 
a small subpopulation with negative PD1 expression, a large 
subpopulation with enhanced PD1 levels/call,  and a popula- 
tion  of *25%  of the cells  that  demonstrated  similar  PD1 
levels to those in M1 (compare with Fig. 6 F). The reconsti- 
tution of expression of H-2 antigens was less striking. TAP2 
transfection increased  H-2D  b expression on 35% of the ceils 
with only a slight increase in mean F.U./cell (Fig.  6, D2 and 
D3),  but  did  not  induce  the  expression  of H-2K  b (Fig.  6 
D4).  Transfection  of the cell line with  a mixture  of TAP1 
and TAP2 did not induce higher levels of class I expression 
than  transfection  with  TAP2 alone  (data not  shown).  Fig. 
6 E  shows the FACS  |  analyses  of an individual clone trans- 
fected with TAP2. In this done,  PD1 expression was com- 
pletely reconstituted (Fig.  6 El),  and H-2D  b molecules were 
expressed in 85% of the cells (Fig. 6, E2 and E3). However, 
the  mean  F.U.  of H-2D  b molecules/cell did not  reach  the 
same as M1 (27 F.U./ce11 in the TAP2 transfected clone and 
92 F.U./cell in M1). The expression of H-2K  b molecules was 
not  reconstituted  (Fig.  6 E4). 
These data indicate that reduced TAP2 expression in Ad12- 
483  Rotem-Yehudar  et al. Table  4.  Densitometric Analysis  of Peptide Transporters, Class I, and f~2m Expression in Adenovirus-transformed Cells 
Cell Line*  TAP1  TAP2  H-2  PD1  B~m 
Densitometric units* (normalized) 
M1  1.0  1.0  1.0  1.0  1.0 
VAD12.42  0.2  0.010  0.3  1.0  0.3 
VAD12.79  0.1  0.008  0.3  1.4  0.3 
A501  12.2  4.3  5.0  5.4  3.0 
A503  1.7  0.8  1.0  1.9  0.9 
A505  11.1  5.3  1.0  1.2  1.3 
ME1  3.3  1.3  0.5  0.8 
ME5  0.9  1.3  1.3  1.3 
* M1 is a normal cell line; VAD12.42 and VAD12.79  are Ad12-transformed  cell lines; A501, A503, and A505 are EIAdS-transformed  cell lines; 
ME1 and ME5 are AdS-transformed  cell lines. 
* The results of densitometric  scanning of the specific hybridizing signals were first divided to that of actin and then normalized  to the value of 
M1 cells. The same blot was  hybridized  to all the probes described above. 
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Figure 6.  Cell surface expression of class I 
antigens is reconstituted in TAP2- but not in 
TAPl-transfected  cells. VAD12.79  cells  (,'t) were 
transfected with PSV2Neo (B), TAP1 (C), and 
TAP2 (D and E). After transfection, the cells 
were selected with 800/lg/ml G418, grown 
to confluence, and pooled for FACS  ~ analyses 
(B-D), or individual colonies were isolated and 
expanded in culture. One of the individual  colo- 
nies transfected with TAP2 is shown in E. Cell 
surface expression is compared to that of M1 
(iv). Antibodies used for FACS  |  analyses  were: 
PT85A (anti-PD1) (~7) in A, B, C and in D1, 
El,  and  F1.  28.14.8 (anti-H-2D  b)  (-~)  in 
A-C, and in D2, E2, and F2. 27.11.13 (anti- 
H-2D  b) (----~) in A-C and in D3, E3, and 
F3.20.8.4S (anti-H-2Kb) (---.~) in A-C and 
in D4, E4, and F4. 
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class I expression. However, the failure of TAP2 gene expres- 
sion to enhance H-2K  b expression and only partially restore 
H-2D  b expression,  indicate  that other factors are also in- 
volved. 
Discussion 
MHC class I molecules are a family of highly polymorphic 
cell surface glycoproteins that have as a primary function the 
property of binding and presenting foreign peptides to CTL 
(61-63).  After activation,  CTL lyse cells that express such 
peptides. This mechanism is known to be important in con- 
trolling pathogenic infections and is also involved in tumor 
resistance. The lack of cell surface MHC class I proteins in 
human tumors, as well as in some virus- and carcinogen- 
induced tumors, undoubtedly interferes with this CTL rec- 
ognition process (2,  13,  64, 65). 
Tumors transformed by the highly oncogenic Ad12 have 
been used as model systems for demonstrating the direct corre- 
lation between tumorigenicity and lack of host immune re- 
sponses due to suppression of class I expression (20-22).  In 
some of the tumors induced by the virus, downregulation 
of class I expression was shown to correlate with decreased 
levels of class I transcription (23-26). However, characteriza- 
tion of a large panel of Ad12-transformed cells in our labora- 
tory revealed that in most cell lines cell surface expression 
was significantly decreased, whereas the steady state levels 
of class I and ~2m mRNA were similar or moderately re- 
duced compared to normal cell lines (27).  It was further 
demonstrated that synthesis and transport of class I mole- 
cules to the cell surface was inefficient in these Ad12-trans- 
formed cell lines (28). 
The transport rate of MHC class I molecules through the 
cell appears to be primarily controlled by their rate of egress 
from the ER to the c/s-Golgi compartment (66,  67). The 
noncovalent  interactions  of the class I  heavy chains with 
/32m (40) and peptide (15) combine to stabilize the complex. 
In cells lacking ~2m, newly synthesized class I heavy chains 
do not attain a mature structure (68, 69), and are inefficiently 
transported to the cell surface (38, 40, 70-73). Similar effects 
were observed in cells with mutated peptide transporter genes 
that are deficient in ER peptides  (10, 15,  16). 
The present paper demonstrates that the highly oncogenic 
Ad12 affects class I antigen levels by downregulating the ex- 
pression of the peptide transporter genes, thereby leading to 
reduced availability of relevant peptides for stable assembly 
and transport of class I molecules to the cell surface. For the 
Ad12-transformed cells, PD1 expression could be enhanced 
by incubation at 26~  (Fig. 2), and H-2K and, especially 
H-2D expression could be enhanced by incubation with rele- 
vant peptides (Figs. 3 and 4). Addition of/32m to the cul- 
ture media did not induce the expression of class I antigens, 
and ~2m in combination with micromolar concentrations of 
peptides did not further enhance the expression of class I an- 
tigens. These results support the conclusion that in these cell 
lines, the limited amount of peptides available for binding 
to class I molecules contributes to the greatly reduced levels 
of expression of these molecules. However, it can not be ruled 
out that limited amounts of endogenous B2m, along with 
possible differences in the affinity of PD1 and H-2 antigens 
for/32m,  might also contribute to the reduced levels of ex- 
pression of  class I molecules. Thus, ifPD1 has a higher affinity 
than H-2 for a limited supply of/~2m molecules, it would 
attain a conformation that is transported, albeit more slowly, 
to the cell surface even in the absence of peptides. This could 
explain why PD1 expression was enhanced in Ad12-trans- 
formed cell lines at 26~  whereas in general H-2 expression 
was not. This possibility is further supported by the results 
obtained with TAP2 transfection. It was shown (Fig. 6) that 
TAP2 transfection nearly fully reconstituted PD1 expression, 
partially reconstituted H-2D expression, and failed to recon- 
stitute H-2K expression. Further experiments, including the 
transfection of/32m expressing plasmid vectors, are required 
to determine whether the inability of TAP2 gene expression 
to fully reconstitute cell surface class I expression is related 
to limited supply of intracellular  ~2m. 
The expression of both TAP1 and TAP2 was suppressed 
in Ad12-transformed cell lines, suggesting that they are regu- 
lated by common transcriptional mechanisms. The fact that 
TAP2 mRNA levels were more markedly decreased by about 
10-fold than TAP1 mRNA levels suggests either the pres- 
ence of multiple suppressive  mechanisms or that some factor(s) 
has a more pronounced effect on the expression of TAP2 than 
TAP1. 
Ad5El-transformed cell lines expressed  higher levels of  TAP1 
and TAP2 mRNA than the normal cell line. A threefold in- 
duction in TAP1 mRNA was also seen in the Ad5-transformed 
cell line ME1, whereas such an effect was not observed in 
another Ad5-transformed cell line, ME5. The differences be- 
tween the cell lines maybe related to the absence  of Ela-mRNA 
in ME5 cells and suggests that Ad5Ela has a transactivating 
effect on the expression of both TAP1 and TAP2. This con- 
clusion is further supported by the observation that in the 
Ad5El-transformed cell A503 there is low level of Ela, the 
expression of TAP1 is activated only by twofold, and the ex- 
pression of TAP2 is not activated. These observations indi- 
cate that gene-specific  sequence  elements associated  with TAP1 
and TAP2 can be either up- or downregulated by viral on- 
cogenes. 
Peptide transporter and class I genes are not activated or 
suppressed to the same extent in adenovirus-transformed cells. 
The difference in TAP1 and TAP2 mRNA levels between 
Ad5E1- and Ad12-transformed cells ranges between 50 and 
100 for TAP1 and more than 500-fold for TAP2, whereas 
B2m and H-2 mRNA levels vary by a maximum of 15-fold, 
and PD1 mRNA level varies by a maximum of 5-fold. Both 
class I and peptide transporter genes were induced by ot//3 
and 3' interferons, but whereas the levels of class I mRNA 
were only induced 2-4-fold, TAP1 and TAP2 mRNA levels 
were induced over 100-fold (Winograd et al., manuscript in 
preparation).  These results suggest that different transcrip- 
tional mechanisms are likely to be involved in the regulation 
of class I and peptide  transporter genes in this system and 
emphasize the conclusion that the suppression of peptide trans- 
485  Rotem-Yehudar  et al. porter gene expression is the critical factor that  limits cell 
surface expression of PD1 and H-2D  b in Adl2-transformed 
cells. 
The fact that class I-specific peptides did not enhance class 
I molecule expression in any of the other cell lines, including 
the Ad5-transformed cell line ME1, which expresses lower 
levels of class I antigens than ME5, is consistent with normal 
levels of peptide transporter  gene expression in these cells. 
The relatively low expression of class I antigens in the ME1 
cell line is most likely related to the low level of dass I mKNA 
in these ceils. 
Transfection  of TAP1, alone, or in combination with TAP2 
did not  enhance  the expression of class  I  molecules in an 
Adl2-transformed cell line.  These data dearly indicate that 
levels of TAP2, and not TAP1, limit  the transport  of PD1 
and H-2D  b molecules;  however,  the inability of TAP2 ex- 
pression to enhance H-2K  b expression and only to partially 
reconstitute H-2D  b expression indicates that a limited pep- 
tide supply is not the only explanation  for reduced class I 
expression in these cell lines. 
The effects of H-2D  b- and H-2Kb-specific peptides were 
quantitatively different.  H-2D  b molecules were induced to 
higher levels, and by lower concentration of peptides, as com- 
pared with H-2K  b molecules. There are several possible ex- 
planations  for this effect: first,  the differences between the 
two class I  antigens might  indicate that  the conformation 
of H-2K  b heavy chains is more dependent  on B2m and/or 
peptide  than  H-2D  b heavy chains,  leading  to less  efficient 
transport  and  less  accumulation  on  the  cell  surface.  This 
possibility is supported by observations that  H-2D  b heavy 
chains do not require/~2m  for cell surface expression (38). 
Another possibility is that the relatively lower levels of H-2K  b 
mRNA  leads to a decrease in the number of H-2K  b mole- 
cules available for peptide binding.  Since the transfection of 
the ceils by TAP2 leads to the reconstitution of H-2D  b and 
PD1 expression but does not affect the expression of H-2K  b 
molecules,  the latter  possibility seems more likely. 
Kestifo et al. (19) recently identified human cancers with 
defective antigen  processing capacities that  do not express 
TAP1  and TAP2 mRNA.  The  authors  did not determine 
whether  this deficiency is the result of the transformation 
event, since the extent of the processing capacity and peptide 
transporter  expression in the normal counterparts  of these 
cell lines was not established. Loss of TAP1 and HLA expres- 
sion was also reported in cervical carcinomas (74). Our results 
suggest that the suppression of peptide transporter genes may 
be caused by the transformation event. Moreover, only cer- 
tain oncogenic viruses seem to have the capacity to cause such 
suppression.  Transformed cells that  do not express peptide 
transporter  genes and,  as a result,  do not transport  class I 
molecules, may undergo  selection in vivo and develop into 
nonimmunogenic  tumors  with  oncogenic potential.  This 
system provides a model for evaluating the roles of various 
factors in the class I biosynthetic pathway in normal and malig- 
nant  cells. 
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